Language selection

Search

Patent 2029240 Summary

Third-party information liability

Some of the information on this Web page has been provided by external sources. The Government of Canada is not responsible for the accuracy, reliability or currency of the information supplied by external sources. Users wishing to rely upon this information should consult directly with the source of the information. Content provided by external sources is not subject to official languages, privacy and accessibility requirements.

Claims and Abstract availability

Any discrepancies in the text and image of the Claims and Abstract are due to differing posting times. Text of the Claims and Abstract are posted:

  • At the time the application is open to public inspection;
  • At the time of issue of the patent (grant).
(12) Patent: (11) CA 2029240
(54) English Title: PHOTOPROTECTION COMPOSITIONS HAVING IMPROVED SUBSTANTIVITY
(54) French Title: COMPOSITIONS DE PHOTOPROTECTION AYANT UNE MEILLEURE SUBSTANTIVITE
Status: Term Expired - Post Grant Beyond Limit
Bibliographic Data
(51) International Patent Classification (IPC):
  • A61K 8/06 (2006.01)
  • A61K 8/92 (2006.01)
  • A61Q 17/04 (2006.01)
(72) Inventors :
  • WOODIN, FREDERICK WINFIELD, JR. (United States of America)
  • DECKNER, GEORGE ENDEL (United States of America)
(73) Owners :
  • RICHARDSON-VICKS INC.
(71) Applicants :
  • RICHARDSON-VICKS INC. (United States of America)
(74) Agent: KIRBY EADES GALE BAKER
(74) Associate agent:
(45) Issued: 1998-12-01
(22) Filed Date: 1990-11-02
(41) Open to Public Inspection: 1992-05-03
Examination requested: 1990-11-02
Availability of licence: N/A
Dedicated to the Public: N/A
(25) Language of filing: English

Patent Cooperation Treaty (PCT): No

(30) Application Priority Data: None

Abstracts

English Abstract


Disclosed are topical compositions having improved substantivity
such as improved water proofing (e.g., resistance to perspiration) and
rub-off resistance useful for protecting the skin from the harmful
effects of ultraviolet irradiation, such as sunburn and sun-induced
premature aging of the skin.


French Abstract

Cette invention concerne des compositions topiques caractérisées par une affinité pour l'eau par exemple (applications antisudorifiques) et une adhérence améliorées, utiles pour la protection de la peau contre les effets nocifs du rayonnement ultraviolet : coups de soleil et vieillissement prématuré de la peau, par exemple.

Claims

Note: Claims are shown in the official language in which they were submitted.


-19-
We claim:
1. An oil-in-water sunscreen emulsion composition having improved
substantivity and moisture resistance for topical use comprising:
(a) from about 1% to about 40% of a sunscreen;
(b) from about 0.01% to about 5% of an emulsifier selected from the
group consisting of alkyl substituted acrylic acid copolymers, TEA
stearate salts, alkali neutralized monoalkyl phosphates, alkali
neutralized dialkyl phosphates, hydroxy cetyl phosphate, and mixtures
thereof, wherein said alkyl substituted acrylic acid copolymers comprise
from about 95.9 to 98.8 weight percent of an olefinically unsaturated
carboxylic monomer selected from the group consisting of acrylic,
methacrylic and ethacrylic acids, about 1 to about 3.5 weight percent of
an acrylate ester of the formula
<IMG>
wherein R is an alkyl radical containing 10 to 30 carbon atoms and R<sub>1</sub>
is hydrogen, methyl or ethyl, and 0.1 to 0.6 weight percent of a
polymerizable cross-linking polyalkenyl polyether of a polyhydric alcohol
containing more than one alkenyl ether group per molecule wherein the
parent polyhydric alcohol contains at least 3 carbon atoms and at least
3 hydroxyl groups;
(c) from about 1% to about 60% of a wax component having a required
HLB of from about 1 to about 10 comprising:
(i) an ester wax selected from the group consisting of C10-40
alcohols esterified with C10-40 fatty acids, diesters of C10-40
fatty acids where the alcohol is propylene glycol, ethylene
glycol or glycerin, polyethylene glycol, polypropylene
glycol, polyglycerin, triglycerides or diglycerides of C10-40
fatty acids, pentaerythritol tri- or tetra- esters of C10-40
fatty acids, C10-40 fatty acids of sorbitan triesters, C10-40
fatty acids of sucrose polyesters having 3-8 moles of
substitution, myristyl myristate, paraffin, synthetic
Fischer-Tropsche waxes, microcrystalline waxes, castor wax,
partially hydrogenated vegetable oils, behenyl behenrate,
myristyl propionate and mixtures thereof; and

-20-
(ii) a wax selected from the group consisting of diester waxes
and triglyceride waxes and mixtures thereof wherein said
diester wax is selected from the group consisting of C18-36
acid glycol ester and propylene glycol diester waxes and
mixtures thereof, and wherein said triglyceride wax is
selected from the group consisting of shea butter, cocoa
butter, C18-36 acid triglyceride, tribehenin, tribehenin
(and) calcium behenate, tristearin, trimyristate, fully
hydrogenated vegetable oils, and mixtures thereof; and
(d) a safe and effective amount of a topical carrier.
2. A sunscreen composition according to claim 1 wherein said wax
component has a required HLB of from about 1 to about 8 and wherein the
ratio of (i) to (ii) ranges from about 5:1 to about 1:1.
3. A sunscreen composition according to claim 2 wherein said wax
component is present at a level of from about 5% to about 35% and wherein
said emulsifier is present at a level of from about 0.05% to about 5%.
4. A sunscreen composition according to claim 3 wherein said sunscreen
active is selected from the group consisting of 2-ethylhexyl p-methoxy-
cinnamate, butylmethoxydibenzoylmethane,2-hydroxy-4-methoxybenzophenone,
2,2' dihydroxy-4-methoxybenzophenone and ethyl hexyl salicylate,
octyl-dimethyl p-aminobenzoicacid, the4-N,N-(2-ethylhexyl)methylaminobenzoic
acid ester of 2,4-dihydroxybenzophenone, the N,N-di-(ethylhexyl)-4-
aminobenzoic acid ester of 4-hydroxydibenzoylmethane, the 4-N,N-(2-
ethylhexyl)methylaminobenzoic acid ester of 4-hydroxydibenzoylmethane,
the 4-N,N-(2-ethylhexyl)methylaminobenzoic acid ester of 2hydroxy-4-(2-
hydroxyethoxy) benzophenone, the 4-N,N-(2-ethylhexyl)-methylaminobenzoic
acid ester of 4-(2-hydroxyethoxy) dibenzoylmethane, the N-N-di-(2-
ethylhexyl)-4-aminobenzoic acid ester of 2-hydroxy-4-(2-hydroxyethoxy)
benzophenone, or the N.N-di-(2-ethylhexyl)-4-aminobenzoic acid ester of
4-(2-hydroxyethoxy)dibenzoylmethane and mixtures thereof.
5. A sunscreen composition according to claim 3 wherein said sunscreen
active is selected from the group consisting of 2-ethylhexyl p-methoxy-
cinnamate, butylmethoxydibenzoylmethane, 2-hydroxy 4-methoxybenzophenone,
octyldimethyl p-aminobenzoic acid and mixtures thereof.

-21-
6. A sunscreen composition according to claim 5 which further comprises
from about 10% to about 50% of an emollient.
7. A sunscreen composition according to claim 6 wherein said emollient
is selected from the group consisting of petrolatum, lanolin, tocopheryl
acetate, USP light mineral oil, USP heavy mineral oil, isohexadecane,
isodecyl neopentanoate, and mixtures thereof.
8. A sunscreen composition according to claim 7 which further comprises
from about 0.01 to about 15% of an emulsifier.
9. The use of a sunscreen composition according to any one of claims
1 to 8 for topical application to the skin of a human or lower animal as
an effective coating against the effects of ultraviolet light.

Description

Note: Descriptions are shown in the official language in which they were submitted.


CA 02029240 1998-04-20
PHOTOPROTECTION COMPOSITIONS HAVING IMPROVED SUBSTANTIVITY
Frederick Winfield Woodin, Jr.
George Endel Deckner
TECHNICAL FIELD
This invention relates to improved topical compositions having
improved substantivity such as improved water-proofing (e.g., resistance
to perspiration) and rub-off resistance useful for protecting the skin
from the harmful effects of ultraviolet irradiation, such as sunburn and
sun-induced premature aging of the skin.
BACKGROUND OF THE INVENTION
The damaging effects of sunlight on skin are well documented.
Contrary to what most people believe, it is not necessary that one
sunbathe to suffer the ill-effects of excessive UV exposure. In fact,
a lot of damage can be done just by routine day-to-day activities in the
sunlight. Some scientists estimate that over 70 percent of the damage
the sun inflicts on the average person's skin over a lifetime is the
result of simply being outdoors or even sitting by a window.
The major short term hazard of prolonged exposure to sunlight is
erythema (i.e. sunburn). The 290 to 320 nanometer wavelength ultraviolet
radiation range, designated as the "UVB" wavelength range, tends to be
the primary cause of erythema. The 320 to 400 nanometer wavelength
ultraviolet radiation range, designated as the "UVA" wavelength range,
also produces erythema.
In addition to the short term hazard or erythema, there are also
long term hazards associated with UV radiation exposure. One of these
long term hazards is malignant changes in the skin surface. Numerous
epidemiologic studies demonstrate a strong relationship between sunlight
exposure and human skin cancer.
Another long term hazard of ultraviolet radiation is premature
aging of the skin. This condition is characterized by wrinkling and
yellowing of the skin, along with other physical changes such as
cracking, telangiectasis (spider vessels), solar keratoses (growths),
ecchymoses (subcutaneous hemorrhagic lesions), and loss of elasticity
(sagging). The adverse effects associated with exposure to UVA and UVB
wavelength radiation are more fully discussed in DeSimone, "Sunscreen and
Suntan Products", Handbook of Nonprescription Druqs, 7th Ed., Chapter 26,
pp. 499-511 (American Pharmaceutical Association,

~-2- ~n~240
Washington, D.C.; 1982); Grove and Forbes, "A Method for Evaluating
the Photoprotection Action of Sunscreen Agents Against UV-A Radia-
tion", International Journal of Cosmetic Science, 4, pp. 15-24 (1982);
and U.S. Patent 4 387,089, DePolo, issued June 7, 1983. Hence
although the immediate effects of ultraviolet radiation may be cosmet-
ically and socially gratifying, the long-term hazards are cumulative
and potentially serious.
The fact that these effects are taken seriously by the general
public is suggested by considering the sun protection products'
market. This market has grown considerably in recent years and many
new products are introduced each year. What used to be looked upon as
a seasonal business is no longer. Sun protection compounds are now
included in a diversity of personal care products, particularly
cosmetic-type products which are worn on a daily basis.
15Sunblock agents are commercially available to protect the skin
from UV radiation. These agents scatter or reflect ultraviolet
radiation. Examples include titanium dioxide and zinc oxide. Howev-
er, compositions containing these agents are opaque, generally unat-
tractive in color, and are viewed as unacceptable for usage on more
20 than just the nose or tops of the ears. Furthermore, these agents are
- very susceptible to rub-off or wear-off resulting in little or no
protection.
The most common agents for sun protection are sunscreens. These
agents exert their effects through chemical means, i.e., they absorb
25 ultraviolet radiation so that it cannot penetrate the skin. Sun-
screens present the user with several problems. For example, they
must be on the surface of the skin at the time of exposure to be
effective. Sunscreens are preventative so one must anticipate being
in the sun. To be most effective, sunscreens must be on the skin as a
continuous uniform film. Delivering such a film to the surface of the
skin is' very difficult; maintaining the film over time is almost
impossible. Sunscreens must remain on the surface of the skin during
exposure. However, sunscreens are easily rubbed off or washed off by
sweating or swimming and can also be lost be penetration into the
35 Sklll.
To overcome these problems, polymers such as ethyl cellulose,
polyvinyl stearate, polyvinyl pyrollidone and eicosene copolymers
A

- ~Q7~4Q
- 3 -
have been used; however these polymers have not proved entirely
satisfactory. Further, sunscreen compositions containing acrylic acid
copolymers have also been disclosed in U.S. Patent 4,663,157 to Brock,
issued May 5, 1987.
It is therefore an object of the present invention to provide a
topical composition in a stable form, the use of which will prevent both
acute (erythema) and chronic (photoaging) effects of exposure to the sun.
It is also an object of the present invention to provide a topical
composition and a method for preventing these deleterious effects of the
sun without interfering with the tanning response.
It is further an object of the present invention to provide a
photoprotection composition with improved aesthetics which adheres to the
skin and which is less susceptible to rub-off, wear-off or wash-off
without the need for polymeric substantivity aids.
It is a still further object of the present invention to provide a
photoprotection composition which can be applied to the skin in advance
of UV exposure without significant loss of waterproofing efficacy.
These and other objects will become readily apparent from the
detailed description that follows.
SUMMARY OF THE INVENTION
The present invention relates to an oil-in-water sunscreen emulsion
composition having improved substantivity and moisture resistance for
topical use comprising:
(a) from about 1% to about 40% of a sunscreen;
(b) from about 0.01% to about 5~ of an emulsifier selected from the
group consisting of alkyl substituted acrylic acid copolymers, TEA
stearate salts, alkali neutralized monoalkyl phosphates, alkali
neutralized dialkyl phosphates, hydroxy cetyl phosphate, and mixtures
thereof, wherein said alkyl substituted acrylic acid copolymers comprise
from about 9S.9 to 98.8 weight percent of an olefinically unsaturated
carboxylic monomer selected from the group consisting of acrylic,
methacrylic and ethacrylic acids, about 1 to about 3.5 weight percent of
an acrylate ester of the formula
Rl O
1 ll
CH2 = C - C - O - R

~-Q ~4~
- 3a -
wherein R is an alkyl radical containing 10 to 30 carbon atoms and R<sub>1</sub>
is hydrogen, methyl or ethyl, and 0.1 to 0.6 weight percent of a
polymerizable cross-linking polyalkenyl polyether of a polyhydric alcohol
containing more than one alkenyl ether group per molecule wherein the
parent polyhydric alcohol contains at least 3 carbon atoms and at least
3 hydroxyl groups;
(c) from about 1% to about 60% of a wax component having a required
HLB of from about 1-to about 10 comprising:
(i) an ester wax selected from the group consisting of C1040
alcohols esterified with Cl040 fatty acids, diesters of C1040
fatty acids where the alcohol is propylene glycol, ethylene
glycol or glycerin, polyethylene glycol, polypropylene
glycol, polyglycerin, triglycerides or diglycerides of C1040
fatty acids, pentaerythritol tri- or tetra- esters of C1040
fatty acids, C1040 fatty acids of sorbitan triesters, C1040
fatty acids of sucrose polyesters having 3-8 moles of
substitution, myristyl myristate, paraffin, synthetic
Fischer-Tropsche waxes, microcrystalline waxes, castor wax,
partially hydrogenated vegetable oils, behenyl behenrate,
myristyl propionate and mixtures thereof; and
(ii) a wax selected from the group consisting of diester waxes and
triglyceride waxes and mixtures thereof wherein said diester
wax is selected from the group consisting of C18-36 acid
glycol ester and propylene glycol diester waxes and mixtures
thereof, and wherein said triglyceride wax is selected from
the group consisting of shea butter, cocoa butter, C18-36
acid triglyceride, tribehenin, tribehenin (and) calcium
behenate, tristearin, trimyristate, fully hydrogenated
vegetable oils, and mixtures thereof; and
(d) a safe and effective amount of a topical carrier.
~ ~ ,

2029240
The present invention further relates to a method of inhibiting
the deleterious effects of ultraviolet light exposure to skin compris-
ing applying a safe and photoprotectively effective amount of these
compositions.
All percentages and ratios used herein are by weight of the total
composition and all measurements made at 25~C, unless otherwise
designated.
DETAILED DESCRIPTION OF THE INVENTION
In accordance with the present invention, moisture resistant skin
treatment compositions, such as sunscreen and sun block formulations,
and moisturizer formulations are provided, which compositions have
improved moisture resistance and substantivity due to the presence
therein of a specific wax component and are preferably in the form of
a oil-in-water emulsion which contains water, emollients, emulsifiers,
thickeners, preservatives, coloring agents, fragrances, antioxidants
and the like and one or more known ultraviolet absorbing compounds (in
the case of sunscreen or sun block formulations).
The formulation of the invention is preferably an oil-in-water
type emulsion since this type of emulsion affords better cosmetic feel
to the product. However, the product could also be formulated as a
water-in-oil emulsion, cream base, or oil base. Depending upon the
choice of ingredients, the formulation has a semi-solid cream-like
consistency which can be packaged in a plastic squeeze tube or it has
a lotion type consistency which can be packaged in a plastic squeeze
container. The container can include a flow-type cap or pump-type
dispenser.
Sunscreens. A wide variety of conventional sunscreening agents
are suitable for use in the present invention. Segarin, et al., at
Chapter VIII, pages 189 et seq., of Cosmetics Science and TechnologY,
disclose numerous suitable agents. Specific suitable sunscreening
agents include, for example: p-Aminobenzoic acid, its salts and its
derivatives (ethyl, isobutyl, glyceryl esters; p-dimethylaminobenzoic
acid); Anthranilates ti.e., o-aminobenzoates; methyl, menthyl, phenyl,
benzyl, phenylethyl, linalyl, terpinyl, and cyclohexenyl esters);
Salicylates (octyl, amyl, phenyl, benzyl, menthyl, glyceryl, and
dipropyleneglycol esters); Cinnamic acid derivatives (menthyl and
benzyl esters, -phenyl cinnamonitrile; butyl cinnamoyl pyruvate);
Dihydroxycinnamic acid derivatives (umbelliferone, methylumbelli-

2029240
ferone, methylaceto-umbelliferone); Trihydroxycinnamic acid deriva-
tives (esculetin, methylesculetin, daphnetin, and the glucosides,
esculin and daphnin); Hydrocarbons (diphenylbutadiene, stilbene);
Dibenzalacetone and benzalacetophenone; Naphtholsulfonates (sodium
salts of 2-naphthol3,6-disulfonic and of 2-naphthol-6,8-disulfonic
acids); Dihydroxy-naphthoic acid and its salts; o- and p-Hydroxybi-
phenyldisulfonates; Coumarin derivatives (7-hydroxy, 7-methyl, 3-
phenyl); Diazoles (2-acetyl-3-bromoindazole, phenyl benzoxazole,
methyl naphthoxazole, various aryl benzothiazoles); Quinine salts
(bisulfate, sulfate, chloride, oleate, and tannate); Quinoline deriva-
tives (8-hydroxyquinoline salts, 2-phenylquinoline); Hydroxy- or
methoxy-substituted benzophenones; Uric and vilouric acids; Tannic
acid and its derivatives (e.g., hexaethylether); (Butyl carbityl)
(6-propyl piperonyl) ether; Hydroquinone; Benzophenones (Oxybenzene,
Sulisbenzone, Dioxybenzone, Benzoresorcinol, 2,2',4,4'-Tetrahydroxy-
benzophenone, 2,2'-Dihydroxy-4,4'-dimethoxybenzophenone, Octabenzone;
4-Isopropyldibenzoylmethane; Butylmethoxydibenzoylmethane; Etocrylene;
and 4-isopropyl-di-benzoylmethane.
Of these, 2-ethylhexyl p-methoxycinnamate, 4,4'-t-butyl methoxy-
dibenzoylmethane, 2-hydroxy-4-methoxybenzophenone, octyldimethyl
p-aminobenzoic acid, digalloyltrioleate, 2,2-dihydroxy-4-methoxybenzo-
phenone, ethyl 4-[bis(hydroxypropyl)]aminobenzoate, 2-ethylhexyl2-
cyano-3,3-diphenylacrylate, 2-ethylhexysalicylate, glyceryl p-amino-
benzoate, 3,3,5-trimethylcyclohexysalicylate, methylanthranilate,
p-dimethyl- aminobenzoic acid or aminobenzoate, 2-ethylhexyl p-di-
methylamino- benzoate, 2-phenylbenzimidazole-5-sulfonic acid 2-(p-
dimethylaminophenyl)-S-sulfonicbenzoxazoic acid and mixtures of these
compounds, are particularly useful.
Preferred sunscreens useful in the compositions of the present
invention are 2-ethylhexyl p-methoxycinnamate, butylmethoxydibenzoyl-
methane, 2-hydroxy-4-methoxybenzophenone, octyldimethyl p-aminobenzoic
acid, 2,2' dihydroxy-4-methoxybenzophenone and ethyl hexyl salicylate
and mixtures thereof.
A safe and photoprotectively effective amount of sunscreen may be
used in the sunscreen compositions of the present invention. By "safe
and photoprotectively" is meant an amount sufficient to provide
photoprotection when the composition is applied not so much as to

-6-
cause any side effects or skin reactions. Generally from about 1% to
about 30%, preferably from about 2% to about 20%, of the composition
may comprise a sunscreening agent. Exact amounts will vary depending
upon the sunscreen chosen and the desired Sun Protection Factor (SPF).
SPF is a commonly used measure of photoprotection of a sunscreen
against erythema. This number is derived from another parameter, the
minimal erythemal dose (MED). MED is defined as the "lease exposure
dose at a specified wavelength that will elicit a delayed erythema
response". The MED indicates the amount of energy reaching the skin
and the responsiveness of the skin to the radiation. The SPF of a
particular photoprotector is obtained by dividing the MED of protected
skin by the MED of unprotected skin. The higher the SPF, the more
effective the agent in preventing sunburn. The SPF value tells how
many times longer a person can stay in the sun with use of the sun-
screen (compared to a person with unprotected skin) before that person
will experience 1 MED. For example, utilizing a sunscreen with an SPF
of 6 will allow an individual to stay in the sun six times longer
before receiving l MED. As the SPF value of a sunscreen increases,
the less chance exists for development of tanning of the skin.
Commercially available sunscreening products have SPF values ranging
from 2 to 50.
Also particularly useful in the present invention are sunscreens
such as those disclosed in Sabatelli, U.S. Patent No. 4,937,370
(granted June 26, 1990) and Sab~telli et al., European
Application Serial No. 87201184.6 (filed June 22, 1987
published February 3, 1988). The sunscreening
agents disclosed therein have, in a single molecule, two distinct
chromophore moieties which exhibit different ultra-violet radiation
absorption spectra. One of the chromophore moieties absorbs pre-
dominantly in the UVB radiation range and the other absorbs strongly
in the UVA radiation range.
These sunscreening agents provide higher efficacy, broader UV
absorption, lower skin penetration and longer lasting efficacy rela-
tive to conventional sunscreens.
Preferred members of this class of sunscreening agents are 4-
N,N-(2-ethylhexyl)methylaminobenzoic acid ester of 2,4-dihydroxybenzo-
phenone; N,N-di-(2-ethylhexyl)-4-aminobenzoic acid ester with 4-hy-
droxydibenzoylmethane; 4-N,N(2-ethylhexyl) methylaminobenzoic acid
B

-7--
.~
ester with 4-hydroxydibenzoylmethane; 4-N,N-(2-ethylhexyl)methylamino-
benzoic acid ester of 2-hydroxy-4-(2-hydroxyethoxy)benzophenone;
4-N,N-(2-ethylhexyl) methylaminobenzoic acid ester of 4-(2-hydroxyeth-
oxy)dibenzoylmethane; N-N-di-(2-ethylhexyl)-4-aminobenzoic acid ester
of 2-hydroxy-4-(2-hydroxyethoxy)benzophenone, and N,N-di-(2-ethyl-
hexyl)4-aminobenzoic acid ester of 4-(2-hydroxyethoxy)dibenzoylmethane
and mixtures thereof.
Emulsifier. The compositions of the present invention also
essentially comprise at least one emulsifier. Preferred is the use of
alkyl substituted acrylic acid copolymers comprising polymers of a
monomeric mixture containing 95.9 to 98.8 weight percent of an ole-
finically unsaturated carboxylic monomer selected from the
group consisting of acrylic, methacrylic and ethacrylic acids, about 1
to about 3.5 weight percent of an acrylate ester of the formula
Rl O
CH2=~ - ~ - 0 - R
wherein R is an alkyl radical containing 10 to 30 carbon atoms and R~
is hydrogen, methyl or ethyl, and 0.1 to 0.6 weight percent of a
polymer-izable cross-linking polyalkenyl polyether of a polyhydric
alcohol containing more than one alkenyl ether group per molecule
wherein the parent polyhydric alcohol contains at least 3 carbon atoms
and at least 3 hydroxyl groups.
Preferably, these polymers contain from about 96 to about 97.9
weight percent of acrylic acid and from about 2.5 to about 3.5 weight
percent of acrylic esters wherein the alkyl group contains 12 to 22
carbon atoms, and Rl is methyl, most preferably the acrylate ester is
stearyl methacrylate. Preferably, the amount of crosslinking monomer
is from about 0.2 to 0.4 weight percent. The preferred crosslinking
monomers are allyl pentaerythritol, trimethylolpropane diallylether or
allyl sucrose. These polymers are fully described in U.S. Patent
4,509,949, Huang et al., issued April 5, 1985.
The carboxylic monomers useful in the production of polymers used
in this invention are the olefinically-unsaturated carboxylic acids
containing at least one activated carbon-to-carbon olefinic double
bond, and at least one carboxyl group.
The preferred carboxylic monomers are the acrylic acids having
the general structure:

~_ -8~ 4 ~
R2
CH 2 =C - COOH,
wherein R2 is a substituent selected from the class consisting of
hydrogen, halogen, and the cyanogen (--C=N) groups, monovalent alkyl
radicals, monovalent alkaryl radicals and monovalent cycloaliphatic
radicals. Of this class, acrylic, methacrylic, and ethacrylic acid
are most preferred. Another useful carboxylic monomer is maleic
anhydride or the acid. The amount of acid used will be from about
95.5 to about 98.9 weight percent of the total monomers used. More
preferably the range will be from about 96 to about 97.9 weight
percent.
The polymers are crosslinked with a polyfunctional vinylidene
monomer containing at least 2 terminal CH2<groups, including for
example, butadiene, isoprene, divinyl benzene, divinyl naphthlene,
allyl acrylates, and the like. Particularly useful crosslinking
monomers for use in preparing the copolymers are polyalkenyl poly-
ethers having more than one alkenyl ether grouping per molecule. The
most useful possess alkenyl groups in which an olefinic double bond is
present attached to a terminal methylene grouping, CH2=C<. Most
preferred from this class is Carbomer 1342 (available as Carbopol 1342
from B.F. Goodrich).
Also useful are TEA stearate salts, alkali neutralized mono- and
di- alkyl phosphates including diethanolamine mono- and di- cetyl
phosphate (available from Givaudan as Amphisol) and hydroxy cetyl
phosphate (available from Henkel as Forlanit E).
The emulsifiers used in the present invention should be dispers-
able (but not soluble) in water.
The emulsifier typically comprises in total from about 0.01% to
about 5%, preferably from about 0.05% to about 3%, and most preferably
from about 0.05% to about 1%, of the compositions of the present
inventlon.
Wax Component. An essential component of the compositions herein
is a wax component having a required HLB of from about 1 to about 10,
preferably from about 1 to about 8, more preferably from about 1 to
about 6 and most preferably from about 1 to about 5 comprising:
(i) an ester wax; and
(ii) a wax selected from the group consisting of diester waxes
and triglyceride waxes and mixtures thereof.
* Trade mark

-9-
Preferably, the ratio of (i) to (ii) ranges from about 10:1 to
about 1:1, more preferably from about 5:1 to about 1:1 and most
preferably from about 3:1 to about 1:1.
The HLB (short for "Hydrophile-Lipophile Balance") value system
is fully described, and values for various materials are provided, in
the publication The HLB Svstem. A Time-Savinq Guide to Emulsifier
Selection (published by ICI Americas Inc., Wilmington, Delaware;
1984).
Useful ester waxes include C10-C40 alcohols esterfied with
o C10-C40 fatty acid, diesters of C10-C40 fatty acid where the alcohol
is propylene glycol, ethylene glycol, polyethylene glycol, polypropy-
lene glycol, polyglycerin, or glycerin, triglycerides or diglycerides
of C10-C40 fatty acid, pentaerythitol tri- or tetra- esters of C10-C40
fatty acids, C10-C40 fatty acids of sorbitan triesters, C10-C40 fatty
acids of sucrose polyesters having 3-8 moles of substitution, myristyl
myristate, paraffin, synthetic waxes such as Fischer-Tropsche waxes,
microcrystalline waxes, castor wax, partially hydrogenated vegetable
oils, behenyl behenrate and myristyl propionate and mixtures thereof.
Useful diester waxes include Synchrowax ERL-C (available from
20 Croda) and propylene glycol diester waxes including ethylene glycol
distearate and glycol distearate. Useful triglyceride waxes include
Shea Butter, Cocoa Butter, Synchrowax HGL-C, Synchrowax~HRC, Synchro-
wax HRS-C (all available from Croda Inc.), tristearin, trimyristate
and fully hydrogenated vegetable oils and mixtures thereof. Preferred
25 is a mixture of diester and triglyceride waxes in a ratio of from
about 5:1 to about 1:1 and more preferably from about 4:1 to about
1:1.
Waxes useful in the compositions of this invention are disclosed
in the following U.S. Patent 4, 049, 792, to Elsnau, issued September
20, 1977; U.S. Patent 4,151,272, to Geary et al., issued April 24,
1975; U.S. Patent 4,229,432, to Geria, issued October 21, 1980; U.S.
Patent 4,280,994~ to Turney, issued July 28, 1981; U.S. Patent
4,126,679, to Davy et al., issued November 21, 1978; and European
Patent Application Publication Number 117,070, to May, published
August 29, 1984, "The Chemistry and Technology of Waxes", A.H. Warth,
2nd Edition, reprinted in 1960, Reinhold Publishing Corporation, pp.
* Trade mark

~ -10-
391-393 and 421; "The Petroleum Chemicals Industry", R.F. Goldstein
and A.L. Waddeam, 3rd Edition (1967), E & F.N. Span Ltd., pp 33-40;
"The Chemistry and Manufacture of Cosmetics", M.G. DeNavarre, 2nd
edition (1970), Van Nostrand ~ Company, pp 354-376; and in "Ency-
clopedia of Chemical Technology:, Vol. 24, Kirk-Othmer, 3rd Edition
(1979) pp 466-481.
OPTIONAL COMPONENTS
Emollients. The compositions of the present invention preferably
comprise at least one emollient. Preferred emollients are volatile
silicone oils, non-volatile emollients, and the highly branched
hydrocarbons known as the Permethyl*99 through 108A series (available
from Permethyl Corporation) and mixtures thereof. The compositions of
the present invention more preferably comprise at least one volatile
silicone oil which functions as a liquid emollient, or especially in a
mixture of volatile silicone oils and non-volatile emollients. The
term "volatile", as used herein, refers to those materials which have
a measurable vapor pressure at ambient temperature.
Volatile silicone oils useful in the compositions of the present
invention are preferably cyclic. The following formula illustrates
cyclic volatile polydimethylsiloxanes useful in the compositions
disclosed herein:
C CH3
[Si ~]n
CH3
wherein n equals about 3 to about 7. Linear polydimethylsiloxanes
contain from about 3 to about 9 silicon atoms per molecule and have
the following general formula:
(CH3)3si-o-[si(cH3) 2 -O]n-Si(CH3)3
wherein n equals about 1 to about 7. Linear volatile silicone materi-
als generally have viscosities of less than about 5 centistokes at25~C while cyclic materials typically have viscosities of less than
about 10 centistokes. A description of various volatile silicone oils
is found in Todd, et al., "Volatile Silicone Fluids for Cosmetics",
Cosmetics & Toiletries, 91, pages 27-32 (1976).
Examples of preferred volatile silicone oils useful herein
include: Dow Corning* 344, Dow Corning 345, and Dow Corning 200
(manufactured by Dow Corning Corp.); Silicone 7207 and Silicone 7158
* Trade mark
' ~2 ",'
~,

4 ~ ~
'~ -11 -
(manufactured by the Union Carbide Corp.); SF 1202 (manufactured by
General Electric); and SWS-03314 (manufactured by SWS Silicones,
Inc.).
The present compositions also preferably contain one or more
non-volatile emollients. Such materials include fatty acid and fatty
alcohol esters, hydrocarbons, non-volatile silicone oils, and mixtures
thereof. Emollients among those useful herein are described in
Cosmetics. Science and Technoloq~ 27-104 (M. Balsam and E. Sagarin,
Ed.; 1972), and U.S. Patent 4,202,879, to Shelton, issued May 13, 1980.
Non-volatile silicone oils useful as an emollient material
include polyalkylsiloxanes, polyalkylarylsiloxanes, and polyether-
siloxane copolymers. The essentially non-voiati~e polyalkyl siloxanes
useful herein include, for example, polydimethyl siloxanes with
viscosities of from about 5 to about 100,000 centistokes at 25~C.
5 Among the preferred non-volatile emollients useful in the present
compositions are the polydimethyl siloxanes having viscosities from
about 10 to about 400 centistokes at 25~C. Such polyalkyl siloxanes
include the Vicasil~series (sold by General Electric Company) and the
Dow Corning 200 series (sold by Dow Corning Corporation). Polyalkyl-
20 aryl siloxanes include polymethylphenyl siloxanes having viscositiesof from about 15 to about 65 centistokes at 25~C. These are avail-
able, for example, as SF 1075 methylphenyl fluid (so]d by General
Electric Company) and 556 Cosmetic Grade Fluid (sold by Dow Corning
Corporation). Useful polyether siloxane copolymers include, for
25 example, a polyoxyalkylene ether copolymer having a viscosity of about
1200 to 1500 centistokes at 25~C. Such a fluid is available as
SF-1066 organosilicone surfactant (sold by General Electric Company).
Polysiloxane ethylene glycol ether copolymers are preferred copolymers
for use in the present compositions.
Non-polar fatty acid and fatty alcohol esters useful herein as an
emollient material include, for example, di-isopropyl adipate, isopro-
pyl myristate, isopropyl palmitate, ethyl hexyl palmitate, isodecyl
neopentanoate C12-C15 alcohol benzoate, diethyl hexyl maleate, PPG 14
butyl ether and PPG-2 myristyl ether propionate. Hydrocarbons such as
isohexadecane (e.g., Permethyl lOlA supplied by Presperse), petrolatum
and USP light (e.g. Klearol~) or heavy (e.g. Kaydol~) mineral oils
are also useful as emollients.
* Trade mark
~:B

20292~0
-12-
The emollients typically comprise in total from about 1% to about
50%, preferably from about 1% to about 25%, and more preferably from
about 1% to about 10X by weight of the compositions of the present
invention.
The following non-limiting examples illustrate embodiments of the
subject invention wherein both essential and optional ingredients are
combined. It i s to be understood that these examples are for illus-
trative purposes only and are not to be construed as limiting the
scope of the invention thereto.
EXAMPLE I
An oil-in-water emulsion prepared by combining the following
components utilizing conventional mixing techniques.
A B C
Comconents % Weiqht % Wei~ht % Wei~ht
Water, purified q.s. q.s. q.s.
Carbopol 1342 0.15 0.15 0.15
Carbopol g34 0.30 0.20 0.20
Escalol 507 (octyl dimethyl PABA)2.00 2.00 2.00
Octyl Methoxycinnamate 2.00 2.00 2.00
Stearic Acid 2.50 2.50 2.50
C12 15 alcohols benzoate 10.00 10.00 10.00
Myristyl myristate 1.00 1.00 1.00
Shea Butter 1.00 1.00 1.00
Triethanolamine 99% 0.45 1.00 0.30
Cyclomethicone 2.00 2.00 2.00
Propyl paraben 0.20 0.20 0.20
Methyl paraben 0.30 0.30 0.30
OMDM Hydantoin 0.20 0.20 0.20
Fragrance 0.50 0.50 0.50
Amphisol (DEA-cetyl phosphate) -- -- 1.0
This emulsion is useful for topical application to inhibit damage
caused by acute or chronic UV exposure. Use of an amount of this
composition sufficient to deposit about 2.0 mg/cm2 of the sunscreening
agent to the skin prior to UV exposure is appropriate.

2029240
-13-
EXAMPLE II
An oil-in-water emulsion prepared by combining the following
components utilizing conventional mixing techniques.
B
Com w nents % w/w %w/w
Water, purified q.s. q.s.
Carbopol 1342 0.15 0.15
Carbopol 934 0.20 0.20
Octyl Dimethyl PABA 8.00 8.00
Octyl Methoxycinnamate 4.00 4.00
Benzophenone-3 4.00 4.00
C 12 -15 alcohols benzoate 5.00 5.00
Octyldodecyl Stearoyl Stearate 5.00 5.00
Castor Wax MP 70 2.00 2.00
Cyclomethicone 3.00 3.00
Triethanolamine 99% 0.35 0.60
Synchrowax HRC 2.00 2.00
Propyl paraben 0.15 0.15
Methyl paraben 0.20 0.20
Benzyl alcohol 0.30 0.30
Fragrance 0.50 0.50
Hydrocetyl phosphate -- 1.00
This emulsion is useful for topical application to inhibit damage
caused by acute or chronic UV exposure. Use of an amount of this
composition sufficient to deposit about 2.0 mg/cm2 of the sunscreening
agent to the skin prior to UV exposure is appropriate.

2029240
-14-
EXAMPLE III
An oil-in-water emulsion prepared by combining the following
components utilizing conventional mixing techniques.
Comwnents % w/w
Water, purified q.s.
Carbopol 1342 0.15
Carbopol 940 0.20
Octyl Dimethyl PABA 8.00
Octyl Methoxycinnamate 3.00
Benzophenone-3 3.00
Isostearyl Benzoate 5.00
Cocoa Butter 2.00
Behenyl Behenate 3.00
Triethanolamine 94% 0.35
Dimethicone (350 cts) 2.00
Propyl paraben 0.20
Methyl paraben 0.35
DMDM Hydantoin 0.30
Fragrance 0.50
This emulsion is useful for topical application to inhibit damage
caused by acute or chronic UV exposure. Use of an amount of this
composition sufficient to deposit about 2.0 mg/cm2 of the sunscreening
agent to the skin prior to UV exposure is appropriate.

-15- ~ 4 ~
-
EXhMPLE IV
An oil-in-water emulsion prepared by combining the following
components utilizing conventional mixing techniques.
Components % w/w
Water, purified q.s.
Carbopol 1342 0.35
Octyl Methoxycinnamate 8.00
Benzophenone-3 3.00
Octyl Salicylate 3.00
Ethylene Glycol stearate 0.50
Synchrowax ERC (synthetic diester) 3.00
Tristearin 2.00
Triethanolamine 99% 0.35
Isostearyl benzoate 10.00
Octyldodecyl stearoyl stearate 5.00
Propyl paraben 0.25
Methyl paraben 0.30
Germall 115 0.30
Fragrance 0.80
This emulsion is useful for topical application to inhibit damage
caused by acute or chronic UV exposure. Use of an amount of this
composition sufficient to deposit about 2.0 mg/cm2 of the sunscreening
agent to the skin prior to UV exposure is appropriate.
* Trade mark
-B

2029240
-16-
EXAMPEE V
An oil-in-water emulsion prepared by combining the following
components utilizing conventional mixing techniques.
ComDonents % w/w
Water, purified q.s.
Carbopol 1342 0.20
Carbopol 940 0.10
Octyl dimethyl PABA 8.00
Menthyl anthranilate 5.00
Cetyl palmitate 3.00
Ethylene Glycol Distearate 3.00
Isodecyl Neopentanoate (Dermol 105) 2.00
Triethanolamine 99~ O.BO
Cyclomethicone (Dow Corning 344) 1.50
Propyl paraben 0.15
Methyl paraben 0.20
DMDM Hydantoin 0.35
Fragrance 1.00
This emulsion is useful for topical application to inhibit damage
caused by acute or chronic UV exposure. Use of an amount of this
composition sufficient to deposit about 2.0 mg/cm2 of the sunscreening
agent to the skin prior to UV exposure is appropriate.

2029240
-17-
EXAMPLE VI
An oil-in-water emulsion prepared by combining the following
components utilizing conventional mixing techniques.
ComDonents ~Ow/w
Water, purified q.s.
Carbopol 934 0.20
Carbopol 1342 0.15
Disodium EDTA 0.10
Octyl dimethyl PABA 2.00
Octyl Methoxycinnamate 2.00
Isostearyl benzoate 10.00
Octyldodecyl stearoyl stearate5.00
Myristyl myristate 2.00
Shea Butter 2.00
Ethylene Glycol stearate 0.20
Triethanolamine g9% 0.35
Cyclomethicone 2.00
Propyl paraben 0.15
Methyl paraben 0.25
Butylene Glycol 2.00
Benzyl alcohol 0.30
DMDM Hydantoin 0.40
Fragrance 1.00
This emulsion is useful for topical application to inhibit damage
caused by acute or chronic UV exposure. Use of an amount of this
composition sufficient to deposit about 2.0 mg/cm2 of the sunscreening
agent to the skin prior to UV exposure is appropriate.

''~ -18- ~ 2 4 ~
EXAMPLE VII
An oil-in-water emulsion prepared by combining the following
components utilizing conventional mixing techniques.
Components % w/w
Water, purified q.s.
Carbopol 1342 0.15
Carbopol 940 0.15
Octyl methoxycinnamate8.00
Octyl salicylate 3-00
Benzophenone-3 3.00
C12-15 alcohols benzoate8.00
Isodecyl Neopentanoate3.00
Wecobee-m (Hydrogenated vegetable oil) 3.00
Satulan (Hydrogenated lanolin) 2.00
Synchrowax HGL 3.00
Dimethicone (350 cts) 2.50
Triethanolamine 99% 0.30
Glycerin 2.00
Propyl paraben 0.20
Methyl paraben 0.30
Germall 115 ~ ~ 40
This emulsion is useful for topical application to inhibit damage
caused by acute or chronic UV exposure. Use of an a~ount of this
composition sufficient to deposit about 2.0 mg/cm2 of the sunscreening
agent to the skin prior to UV exposure is appropriate.
A

Representative Drawing

Sorry, the representative drawing for patent document number 2029240 was not found.

Administrative Status

2024-08-01:As part of the Next Generation Patents (NGP) transition, the Canadian Patents Database (CPD) now contains a more detailed Event History, which replicates the Event Log of our new back-office solution.

Please note that "Inactive:" events refers to events no longer in use in our new back-office solution.

For a clearer understanding of the status of the application/patent presented on this page, the site Disclaimer , as well as the definitions for Patent , Event History , Maintenance Fee  and Payment History  should be consulted.

Event History

Description Date
Inactive: IPC deactivated 2013-01-19
Inactive: IPC assigned 2012-03-22
Inactive: IPC assigned 2012-03-22
Inactive: IPC assigned 2012-03-22
Inactive: First IPC assigned 2012-03-22
Inactive: Expired (new Act pat) 2010-11-02
Grant by Issuance 1998-12-01
Inactive: Final fee received 1998-07-30
Pre-grant 1998-07-30
Inactive: Received pages at allowance 1998-04-20
Letter Sent 1998-02-16
Notice of Allowance is Issued 1998-02-16
Notice of Allowance is Issued 1998-02-16
Inactive: Application prosecuted on TS as of Log entry date 1998-02-09
Inactive: Status info is complete as of Log entry date 1998-02-09
Inactive: IPC removed 1998-01-05
Inactive: First IPC assigned 1998-01-05
Inactive: IPC assigned 1998-01-05
Inactive: Approved for allowance (AFA) 1998-01-02
Application Published (Open to Public Inspection) 1992-05-03
Request for Examination Requirements Determined Compliant 1990-11-02
All Requirements for Examination Determined Compliant 1990-11-02

Abandonment History

There is no abandonment history.

Maintenance Fee

The last payment was received on 1998-09-24

Note : If the full payment has not been received on or before the date indicated, a further fee may be required which may be one of the following

  • the reinstatement fee;
  • the late payment fee; or
  • additional fee to reverse deemed expiry.

Please refer to the CIPO Patent Fees web page to see all current fee amounts.

Fee History

Fee Type Anniversary Year Due Date Paid Date
MF (application, 7th anniv.) - standard 07 1997-11-03 1997-10-21
Final fee - standard 1998-07-30
MF (application, 8th anniv.) - standard 08 1998-11-02 1998-09-24
MF (patent, 9th anniv.) - standard 1999-11-02 1999-10-04
MF (patent, 10th anniv.) - standard 2000-11-02 2000-10-03
MF (patent, 11th anniv.) - standard 2001-11-02 2001-10-05
MF (patent, 12th anniv.) - standard 2002-11-04 2002-10-02
MF (patent, 13th anniv.) - standard 2003-11-03 2003-10-03
MF (patent, 14th anniv.) - standard 2004-11-02 2004-10-04
MF (patent, 15th anniv.) - standard 2005-11-02 2005-10-05
MF (patent, 16th anniv.) - standard 2006-11-02 2006-10-05
MF (patent, 17th anniv.) - standard 2007-11-02 2007-10-09
MF (patent, 18th anniv.) - standard 2008-11-03 2008-10-09
MF (patent, 19th anniv.) - standard 2009-11-02 2009-10-08
Owners on Record

Note: Records showing the ownership history in alphabetical order.

Current Owners on Record
RICHARDSON-VICKS INC.
Past Owners on Record
FREDERICK WINFIELD, JR. WOODIN
GEORGE ENDEL DECKNER
Past Owners that do not appear in the "Owners on Record" listing will appear in other documentation within the application.
Documents

To view selected files, please enter reCAPTCHA code :



To view images, click a link in the Document Description column. To download the documents, select one or more checkboxes in the first column and then click the "Download Selected in PDF format (Zip Archive)" or the "Download Selected as Single PDF" button.

List of published and non-published patent-specific documents on the CPD .

If you have any difficulty accessing content, you can call the Client Service Centre at 1-866-997-1936 or send them an e-mail at CIPO Client Service Centre.


Document
Description 
Date
(yyyy-mm-dd) 
Number of pages   Size of Image (KB) 
Cover Page 1998-11-17 1 27
Description 1998-04-20 19 755
Claims 1994-01-20 3 111
Description 1994-01-20 18 654
Cover Page 1994-01-20 1 15
Abstract 1994-01-20 1 11
Claims 1997-12-10 3 120
Description 1997-12-10 19 752
Commissioner's Notice - Application Found Allowable 1998-02-16 1 165
Correspondence 1998-02-16 1 100
Correspondence 1998-04-20 2 84
Correspondence 1998-07-30 1 43
Fees 1996-10-21 1 73
Fees 1995-10-25 1 63
Fees 1994-10-27 1 50
Fees 1993-10-18 1 58
Fees 1992-09-23 1 33
Prosecution correspondence 1997-11-14 1 30
Prosecution correspondence 1997-05-08 1 33
Prosecution correspondence 1996-09-12 2 50
Prosecution correspondence 1996-02-26 3 104
Examiner Requisition 1997-05-20 1 50
Prosecution correspondence 1996-05-14 2 65
Examiner Requisition 1995-08-25 2 68